Stem Holdings, Inc. (OTCQB: STMH CSE: STEM) an innovative corporation with vertically integrated cannabis operations in Oregon, Nevada, California and Oklahoma, is pleased to announce the appointment of Dennis A. Suskind, former General Partner for Goldman Sachs & Co. LLC, to Stem’s Advisory Committee.
“We are honored to have Dennis Suskind serve as an advisor to our company,”
said Stem’s CEO, Adam Berk.
“Mr. Suskind has a distinguished history of providing guidance and leadership to many respected organizations. His insight will be incredibly valuable to Stem as we leverage our multi-state, vertically integrated platform to achieve growth in the coming years. “
This is a high-profile hire for the company, as they recently announced a major milestone in receiving a cannabis growing licence in St. Vincent & the Grenadines. The license permits Stem Holdings, Inc. to cultivate cannabis locally for research and development, prior to the issuance of new licenses under the newly established Medical Cannabis Authority. Under the order, Stem Holdings, Inc. will construct a modern research facility which will house the cultivation of a variety of high cannabidiol (CBD) and low tetrahydrocannabinol (THC) cultivars.
Just days ago, the company updated their float, which is catching the attention of investors due to how attractive it is for a company of this size.
Now that the company has begun development after securing a number of deals, investors are watching closely as STMH recently traded at $7.16 within a 52-week period. This is significant because currently it is trading at $1.60, with an updated low float, news starting to surface now, large corporate hires, new cannabis licences and technicals pointing to a possible bull run.